These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38974278)

  • 41. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
    Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Landslide disasters in eastern Uganda: post-traumatic stress disorder and its correlates among survivors in Bududa district.
    Kabunga A; Okalo P; Nalwoga V; Apili B
    BMC Psychol; 2022 Dec; 10(1):287. PubMed ID: 36471406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM; Francois J; Sreenivasan N; Wannemuehler K; Faye PC; Tohme RA; Delly P; Deslouches YG; Etheart MD; Dismer AM; Patel R; Date K
    Vaccine; 2019 Oct; 37(43):6348-6355. PubMed ID: 31521413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
    Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
    Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholera and diarrheal diseases in Cuamba District, Niassa Province, Mozambique: Systematic healthcare facility-based surveillance strengthening, characteristics of suspected cholera and diarrheal patients, and incidence of diarrheal diseases.
    Semá Baltazar C; Langa JP; Baloi LD; Elias Chitio JJ; Manuel JA; Mboane RBJ; Assane S; Omar A; Manso M; Capitine I; Luiz N; Mukasa D; Jang GH; Park JY; Marks F; Mraidi R; Pak GD; Kim DR; Park SE
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0011843. PubMed ID: 38687808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.
    Chowdhury F; Aziz AB; Ahmmed F; Ahmed T; Kang SS; Im J; Park J; Tadesse BT; Islam MT; Kim DR; Hoque M; Pak G; Khanam F; McMillan NAJ; Liu X; Zaman K; Khan AI; Kim JH; Marks F; Qadri F; Clemens JD
    Vaccine; 2023 Mar; 41(14):2368-2375. PubMed ID: 36898931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multisectoral approach for the control of cholera outbreak - lessons and challenges from Lusaka district - Zambia, October 2023 - February 2024.
    Kateule E; Nzila O; Ngosa W; Mfume F; Shimangwala C; Gama A; Msiska S
    Pan Afr Med J; 2024; 48():19. PubMed ID: 39184850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
    Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F
    Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679
    [No Abstract]   [Full Text] [Related]  

  • 53. Cholera outbreak caused by drinking unprotected well water contaminated with faeces from an open storm water drainage: Kampala City, Uganda, January 2019.
    Eurien D; Mirembe BB; Musewa A; Kisaakye E; Kwesiga B; Ogole F; Ayen DO; Kadobera D; Bulage L; Ario AR; Zhu BP
    BMC Infect Dis; 2021 Dec; 21(1):1281. PubMed ID: 34961483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    Ferreras E; Matapo B; Chizema-Kawesha E; Chewe O; Mzyece H; Blake A; Moonde L; Zulu G; Poncin M; Sinyange N; Kasese-Chanda N; Phiri C; Malama K; Mukonka V; Cohuet S; Uzzeni F; Ciglenecki I; Danovaro-Holliday MC; Luquero FJ; Pezzoli L
    PLoS One; 2019; 14(8):e0219040. PubMed ID: 31469853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of oral cholera vaccine in Haiti: a rural demonstration project.
    Ivers LC; Teng JE; Lascher J; Raymond M; Weigel J; Victor N; Jerome JG; Hilaire IJ; Almazor CP; Ternier R; Cadet J; Francois J; Guillaume FD; Farmer PE
    Am J Trop Med Hyg; 2013 Oct; 89(4):617-624. PubMed ID: 24106187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study.
    Kim JH; Mogasale V; Burgess C; Wierzba TF
    Vaccine; 2016 Apr; 34(18):2113-20. PubMed ID: 26993337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The case for ring vaccinations with special consideration of oral cholera vaccines.
    Deen J; von Seidlein L
    Hum Vaccin Immunother; 2018; 14(8):2069-2074. PubMed ID: 29630444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016.
    Bwire G; Ali M; Sack DA; Nakinsige A; Naigaga M; Debes AK; Ngwa MC; Brooks WA; Garimoi Orach C
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006118. PubMed ID: 29284003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.
    Date KA; Vicari A; Hyde TB; Mintz E; Danovaro-Holliday MC; Henry A; Tappero JW; Roels TH; Abrams J; Burkholder BT; Ruiz-Matus C; Andrus J; Dietz V
    Emerg Infect Dis; 2011 Nov; 17(11):2105-12. PubMed ID: 22099114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.